An in vitro reaction between lymphoid cells and target fibroblastic cells: a possible model for in vivo rejection of haemopoietic allografts.
D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology; D001853:Bone Marrow / Q000276:immunology; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002454:Cell Differentiation; D003165:Complement System Proteins; D003520:Cyclophosphamide / Q000494:pharmacology; D003601:Cytotoxicity Tests, Immunologic; D004622:Embryo, Mammalian; D005347:Fibroblasts / Q000276:immunology*; D006084:Graft Rejection; D006412:Hematopoietic Stem Cells; D037102:Lectins; D008198:Lymph Nodes / Q000166:cytology / Q000276:immunology; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D051379:Mice; D008954:Models, Biological; D009132:Muscles / Q000166:cytology; D011830:Radiation Effects; D013154:Spleen / Q000276:immunology; D013934:Thymectomy; D013950:Thymus Gland / Q000276:immunology; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D037102:Lectins; D003520:Cyclophosphamide; D003165:Complement System Proteins